Search result for 'overactive bladder'

Lupin has launched a generic version of Mirabegron extended-release tablets for overactive bladder in the US, following USFDA approval. The drug is a generic equivalent of Astellas Pharma's...

Lupin launches generic Mirabegron extended-release tablets (25 mg) in the US market, approved by USFDA. The drug treats overactive bladder.

Zydus Lifesciences has launched a generic medication for overactive bladder in the US market. The drug, Mirabegron, is expected to increase access and availability for patients.